Lin H S, Weinkam R J
J Med Chem. 1981 Jun;24(6):761-3. doi: 10.1021/jm00138a025.
The in vitro metabolism of the anticancer agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) has been studied in male Fischer 344 rat liver microsomal preparations. The previously identified product. 1,3-bis(2-chloroethyl)urea (BCU), has been shown to be the major metabolite. Stable isotope labeling and mass spectral analysis of isolated metabolites indicate that BCU is formed exclusively from the metabolic denitrosation of BCNU. The rate of BCNU chemical decomposition in rat liver microsomal preparations deficient in NADPH and the metabolic disappearance rate in preparations containing added NADPH were measured and compared with the measured rate of metabolic formation of BCU under the same conditions. The rate of NADPH-dependent BCNU metabolism and BCU formation are equal within experimental error. BCNU was found to inhibit the rat liver 9000 g supernatant metabolism of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
已在雄性费希尔344大鼠肝微粒体制剂中研究了抗癌剂1,3-双(2-氯乙基)-1-亚硝基脲(BCNU)的体外代谢。先前鉴定出的产物1,3-双(2-氯乙基)脲(BCU)已被证明是主要代谢物。对分离出的代谢物进行稳定同位素标记和质谱分析表明,BCU仅由BCNU的代谢脱亚硝基作用形成。测定了缺乏NADPH的大鼠肝微粒体制剂中BCNU的化学分解速率以及含有添加NADPH的制剂中的代谢消失速率,并与在相同条件下测得的BCU代谢形成速率进行了比较。在实验误差范围内,NADPH依赖性BCNU代谢和BCU形成的速率相等。发现BCNU可抑制大鼠肝脏9000g上清液对1-(2-氯乙基)-3-环己基-1-亚硝基脲(CCNU)的代谢。